Takeda FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC This is the first time the FDA has approved a drug specifically for NSCLC patients who harbor rare EGFR Exon20 insertion mutations. Takeda Pharmaceutical, Rady Children's Partner on Rare Genetic Disease Drug Development The partners will use data derived from whole-genome sequencing to discover and develop treatments for rare child-onset genetic diseases. FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor The agency approved Foundation Medicine's tissue-based, next-generation sequencing test to identify patients with ALK-positive NSCLC eligible for Alunbrig. Evotec, Takeda Pharmaceuticals Partner on RNA-Targeting Drug Development The companies will work together to identify and develop small molecule drugs against RNA targets that fit within Takeda's disease areas of focus. UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects Led by a group of 10 biopharmaceutical firms, the project will use Olink's proteomic technology to look at participants' plasma levels of roughly 1,500 proteins. Sep 18, 2020 Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies Jul 8, 2020 Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases May 26, 2020 Takeda's Alunbrig Gets First-Line FDA Approval With Abbott CDx in ALK-Positive Lung Cancer Apr 27, 2020 Rockefeller University, Cerevance Pursue Pooled Nuclei Sequencing to Target Brain Cell Types Premium Aug 15, 2019 HiFiBio Bets on Single-Cell Methods to Boost Drug Discovery Premium Oct 9, 2018 ERS Genomics Licenses CRISPR-Cas9 Genome Editing IP to GenAhead Bio May 1, 2018 Thermo Fisher Inks New Pharma Partnerships to Expand CDx Use of Oncomine NGS Test Nov 7, 2016 Takeda Adopts Definiens Biomarker Analysis Platform Sep 12, 2016 HudsonAlpha to Provide Sequencing Services for ORIEN Cancer Initiative Jun 30, 2016 Exosome Diagnostics Inks RNA-Seq Collaboration With Takeda Jun 16, 2016 Takeda, M2Gen Launch Genomic Data Program to Match Patients to Cancer Trials May 28, 2015 Takeda Partners with Sanford-Burnham on Heart Failure Research Jul 16, 2014 Researchers Use APOE-TOMM40 Haplotypes to Explain African-Americans' Unique Alzheimer's Risk Profile Premium Apr 16, 2014 Seattle Genetics Receives Milestone Payments from Takeda for Adcetris Sales Premium Mar 12, 2014 Pharma Slowly Adapting to Complexities and Challenges of Developing Personalized Medicine Premium Sep 4, 2013 Takeda, Zinfandel Launch TOMMORROW Trial to Evaluate Alzheimer's Onset Risk Algorithm, AD-4833 Premium Jul 24, 2013 Takeda, Zinfandel Evaluate Genetic Risk Algorithm Ahead of Alzheimer's Delay Study with Diabetes Rx Premium Jun 19, 2013 Innovation Boom or Bust? Industry Gauges Impact of SCOTUS Ruling on Gene Patents Premium Oct 10, 2012 Alzheimer's Prevention Study in Genetically Defined High-Risk Patients Includes Roche, Lilly Drugs Premium Jul 25, 2012 Rodent Study Suggests Low-Dose Pioglitazone May Improve Cognitive Function in Alzheimer's Patients Premium Load More Breaking News Qiagen Gets CE Mark for Therascreen EGFR Plus RGQ Kit for Non-Small Cell Lung Cancer New CRISPR Approach Enables Gene Editing in Cockroaches, Potentially Many Insect Species Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology Mirvie Raises $60M in Series B Funding Interpace Biosciences Posts 6 Percent Revenue Increase in Q1 Ginkgo Bioworks Q1 Revenues More Than Triple The Scan Booster for Kids The US Food and Drug Administration has authorized a booster dose of Pfizer-BioNTech's SARS-CoV-2 vaccine for 5-to-11-year olds, the Washington Post reports. Novavax Anticipates Authorization Novavax expects to receive US Food and Drug Administration authorization for vaccine soon, according to CNBC. Some Old Microbes Indeed Vice reports that researchers may have uncovered 830-million-year-old microbes. PNAS Papers on Meiotic Crossover, RNA Targeting, SNAT7 mTORC1 Regulation In PNAS this week: meiotic crossover formation in C. elegans, approach to identify small molecules affecting RNA activity, and more.